Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Norwegian Laparoscopic Aortic Surgery Trial
Brief Summary:
Patients with severe atherosclerotic occlusive disease can be operated with an aortobifemoral bypass(ABFB)through a median laparotomy. Since 1993, the vary operation has also been performed laparoscopically. The laparoscopic ABFB operation claims to be minimally invasive as compared to the open ABFB. The cohort studies published so far have shown that although a longer operation time with the laparoscopic procedure as compared to the open surgery, the patients have a shorter hospital stay, lesser perioperative bleeding, fewer systemic complications and earlier reconvalescence.
However, no randomized control trial has yet been published to compare the two procedures.
In the NLAST-study, which is a multicenter randomized control trial, the patients with TASC type D atherosclerotic lesion shall be randomized to either totally laparoscopic aortobifemoral bypass operation (LABFB)or an open ABFB operation.